NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/09/2025
Back to search
Official data from USPTO
APERIO CLINICAL OUTCOMES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APERIO CLINICAL OUTCOMES
ST13
US500000088438039Class
42
Filing
88438039
Registration
5926109
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
05/10/2025
Trademark type
Word
Nice classes
42
Filing date
05/20/2019
Registration date
12/03/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/09/2025
Last transaction
05/10/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
01/18/2018
First use in commerce
01/18/2018
Drawing code
4
Owner type
16
Owner location
Durham, NC
Examiner
NADELMAN, ANDREA
Current location
Historical data usage
Holders and representatives
Holders
Aperio Clinical Outcomes, LLC
Aperio Clinical Outcomes, LLC
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Contract research organization (CRO) servicesconducting clinical trials for others; Contract research organization (CRO) servicesmonitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for othersclinical trial project management and quality assurance for othersmedical writing of investigational drug protocols and clinical study reports for othersdata management and electronic data capture (EDC) database programming of clinical trials and biostatistical analysis for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medicalpharmaceuticalbiotechnology and medical device fields for others
Publications
History of USPTO decisions and trademark events.
13 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/17/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2019
PUBO
PUBLISHED FOR OPPOSITION
09/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2019
DOCK
ASSIGNED TO EXAMINER
08/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2019
NWAP
NEW APPLICATION ENTERED
05/23/2019
Continuous trademark protection
Get notified about every new filing that threatens APERIO CLINICAL OUTCOMES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.